This series provides attendees an intimate session with an expert specialist who will lead an engaging topic-focused discussion. With seating limited to 25 attendees per breakfast and lunch, each session will be highly interactive and provide an expanded opportunity for learning. An additional fee applies for each session and is not included in standard registration fees.

Friday Breakfast

November 10, 2017
6:45 am – 7:45 am

  • Optimizing biologics in pediatric IBD
    Anne Griffiths, MD
  • Treating pediatric IBD with new (and old) therapies: Is the approach different in kids?
    Marla Dubinsky, MD
  • Medical-surgical considerations and management of postoperative Crohn’s disease: Where are we today?
    Miguel D. Regueiro, MD, FACG and Javier P. Salgado, MD

Friday Lunch

November 10, 2017
12:45 pm – 1:45 pm

  • Approach to dysplasia in ulcerative colitis: Endoscopic resection vs. surgery
    Paulo G. Kotze, MD and Thomas A. Ullman, MD, FACG
  • Medical-surgical considerations and management of perianal Crohn’s disease: Where are we today?
    Russell D. Cohen, MD, FACG and Philip Fleshner, MD
  • IBD and pregnancy/breastfeeding: What do I do?
    Sunanda V. Kane, MD, MSPH, FACG

Saturday Breakfast

November 11, 2017
6:45 am – 7:45 am

  • Cannabis and other alternative therapies for IBD: The good, the bad, and the ugly of marijuana
    Eva Szigethy, MD, PhD, FACG
  • What do you do and what do you tell your IBD patients traveling the world?
    Gil Y. Melmed, MD, FACG
  • Considerations for the patient, male and female, wanting to have a baby
    Millie D. Long, MD, MPH, FACG

Saturday Lunch

November 11, 2017
12:45 pm – 1:45 pm

  • J-pouch digest: Complicated J-pouch decisions
    Bo Shen, MD, FACG and Scott Strong, MD
  • How should we use therapeutic drug monitoring? Cases from my practice
    Adam S. Cheifetz, MD, FACG
  • How to improve quality of care and patient reported outcomes in IBD
    Peter D. Higgins, MD, PhD, MSc